washingtonpost.com  > Politics > Special Reports > Stem Cell Research

Kerry Takes On Issue of Embryo Research

Campaign Broadens Challenge to Include President's Commitment to Science

By Ceci Connolly
Washington Post Staff Writer
Sunday, August 8, 2004; Page A05

Seizing an issue with overwhelming bipartisan support, the Kerry campaign is marking the third anniversary of President Bush's decision to limit federal embryonic stem cell research with a series of high-profile events this week that call into question the administration's commitment to science and breakthrough medicine.

Sen. John F. Kerry (Mass.), building on a theme he and Ronald Prescott Reagan introduced at the Democratic National Convention, launched the latest attack yesterday in the weekly Democratic radio address, pledging that when he takes office the Bush restrictions will be lifted and he will "stand up for science."

_____Full Coverage_____
Stem Cell Research
Cloning
spacer
2004 Campaign
___ Compare Bush and Kerry ___
spacer
Bush and Kerry Candidate Positions
A side-by-side comparison of the stands taken by President Bush and Sen. John F. Kerry.

___ More Election Coverage ___
spacer
Electoral College Map: Post analysis, polls and recent voting history from 16 swing states.
spacer
Live Discussions: Q&A With Post Reporters, Newsmakers and Pundits
spacer
News From the Trail: Updates and Analysis on Presidential, Senate and House Races




Friday's Question:
It was not until the early 20th century that the Senate enacted rules allowing members to end filibusters and unlimited debate. How many votes were required to invoke cloture when the Senate first adopted the rule in 1917?
51
60
64
67


_____Biotech Headlines_____
Columbia To Lose Novavax Headquarters (The Washington Post, Aug 7, 2004)
Geneticist Denies Abuse Charges (The Washington Post, Aug 6, 2004)
NIH to Set Stiff Restrictions on Outside Consulting (The Washington Post, Aug 4, 2004)
More Biotech News
_____Free E-mail Newsletters_____
• Politics News & Analysis
• Campaign Report
• Federal Insider
• News Alert

Tomorrow, daughter Vanessa Kerry, running mate Sen. John Edwards (N.C.), doctors, patients and scientists will hold briefings, rallies and news conferences to highlight an issue on which they say Bush is far from the mainstream.

"For families and for patients, too many of us have anniversaries we have to mark, whether it's the anniversary of an accident or a death or date of diagnosis," said David Carmel, who left his private sector job to coordinate medical research outreach for Kerry. "We hope to make Aug. 9 the last anniversary of federal restrictions on stem cell research."

Though they are not working with the Kerry team, several nonpartisan organizations will reinforce the Democrat's message. Former attorney general Janet Reno, who has Parkinson's disease, will join a rally sponsored by the Genetics Policy Institute in Miami, while the New York-based Committee for the Advancement of Stem Cell Research is running radio ads that warn that a vote for Ralph Nader means "four more years of delays," co-founder Frank Cocozzelli said.

Rarely has a technical scientific matter rated such prominence in a presidential contest. But pollsters on both sides say that in a close race in which the electorate is so polarized, stem cell research -- or, more broadly, science and medicine -- may be one of the few topics with the power to lure independents and moderates to the Democratic ticket.

"This is an issue with legs," said Democratic pollster Peter Hart, who has measured 70 percent support nationwide for embryonic stem cell research. He predicted that Kerry will attract support from disease sufferers and families who otherwise agree with Bush on public policy but feel "alienated" by his decision to restrict federal funding for embryonic stem cell research.

On Aug. 9, 2001, Bush chose stem cell research as the topic for his first prime-time televised address, announcing that he would permit tax dollars to be spent only on research involving embryonic stem cells that existed at that time.

"Embryonic stem cell research offers both great promise and great peril, so I have decided we must proceed with great care," he said. "This allows us to explore the promise and potential of stem cell research without crossing a fundamental moral line by providing taxpayer funding that would sanction or encourage further destruction of human embryos that have at least the potential for life."

Scientists are eager to study the primitive cells extracted from 5-day-old embryos because they have the rare ability to morph into virtually any type of human tissue. That could pave the way to treat patients with "replicated" tissue cells in situations such as spinal cord injuries, Parkinson's and juvenile diabetes.

Opponents, including antiabortion activists and some religious leaders, object because the work involves the destruction of an embryo. They advocate research on adult or fetal tissue stem cells instead.

Now, three years after administration officials claimed they would make 78 cell lines and $100 million a year available for the controversial research, scientists and patient groups complain that the Bush policy is inadequate. Fewer than two dozen cell lines are available, and the budget for embryonic stem cell studies is $25 million.

"Here in America, we don't sacrifice science for ideology," Kerry said in his radio address. "Every day that we wait, more than 3,000 Americans lose their lives to diseases that may someday be treatable because of stem cell research."

Bush allies point out that there are no limits on privately funded embryonic stem cell research and say an expansion of the federal program would probably mean taking money from other scientific work.


CONTINUED    1 2    Next >

© 2004 The Washington Post Company